Results 61 to 70 of about 4,196 (213)

The Unyielding Enigma

open access: yesJournal of Indian Academy of Oral Medicine and Radiology
Scleroderma, an autoimmune connective tissue disorder marked by profound fibrosis in visceral organs, skin, and blood vessels, exhibits oral manifestations typically initiating with tongue rigidity and facial skin alterations. It presents with a plethora
Hima John   +3 more
doaj   +1 more source

A case of eosinophilic fasciitis and generalized morphea overlap [PDF]

open access: yes, 2020
A 60-year old man developed skin hardening and edema on his extremities. Although he had been treated with oral prednisolone at another hospital, skin stiffness relapsed during tapering of prednisolone.
Watanabe, Yukina   +2 more
core  

Skin Gene Expression Correlates of Severity of Interstitial Lung Disease in Systemic Sclerosis [PDF]

open access: yes, 2013
Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/100260/1/art38101 ...
Assassi, Shervin   +10 more
core   +1 more source

Anti-cancer therapy related hand-foot syndrome in patients with systemic sclerosis: Case series and literature review

open access: yesCurrent Problems in Cancer: Case Reports, 2020
Hand-foot syndrome (HFS) is a common chemotherapy side effect, typically managed with supportive care including preemptive cooling. Systemic sclerosis (SSc) is an autoimmune disease characterized by vascular dysfunction and fibrosis of multiple organs ...
Madison Grinnell   +4 more
doaj   +1 more source

Co-existence of Pulmonary Tuberculosis and Interstitial Lung Disease in a Patient of Connective Tissue Disorder: A Case Report [PDF]

open access: yesJournal of Clinical and Diagnostic Research, 2020
Pulmonary involvement is common in patients with systemic sclerosis. The most common underlying histology is Non Specific Interstitial Pneumonia (NSIP).
Huma Firdaus   +4 more
doaj   +1 more source

Clinical Characteristics and Evolution of Interstitial Lung Disease in Subtypes of Idiopathic Inflammatory Myositis With Prevalent Lung Manifestation: A Retrospective Analysis

open access: yesACR Open Rheumatology, Volume 8, Issue 2, February 2026.
Objective Interstitial lung disease (ILD) is common in idiopathic inflammatory myositis (IIM), particularly in antisynthetase syndrome (ASyS), antimelanoma differentiation‐associated protein 5 (anti‐MDA5) syndrome, and scleromyositis. ILD can progress despite resolution of extrapulmonary symptoms, termed postmyopathic progressive pulmonary fibrosis ...
Julia Clark   +5 more
wiley   +1 more source

Clinical and Immunological Features of Anti-centromere Antibody-Positive Primary Sjögren’s Syndrome

open access: yesRheumatology and Therapy, 2018
Introduction Anti-centromere antibody (ACA)-positive Sjögren’s syndrome (SS) is considered a subtype of SS. ACA-positive SS patients display several features, such as Raynaud’s phenomenon, sclerodactyly, and extraglandular dysfunction.
Masako Tsukamoto   +2 more
doaj   +1 more source

Síndrome de CREST e hipertensão pulmonar: prognóstico sombrio.

open access: yesActa Médica Portuguesa, 2004
The CREST syndrome initially described as a limited, more indolent form of diffuse scleroderma, is characterized by calcinosis, Raynaud's phenomenon, esophageal dysfunction, sclerodactyly, and telangiectasias.
Ana C Carneiro   +2 more
doaj   +1 more source

Immunochip analysis identifies multiple susceptibility loci for systemic sclerosis [PDF]

open access: yes, 2014
In this study, 1,833 systemic sclerosis (SSc) cases and 3,466 controls were genotyped with the Immunochip array. Classical alleles, amino acid residues, and SNPs across the human leukocyte antigen (HLA) region were imputed and tested.
  +75 more
core   +1 more source

Anti‐Eukaryotic Initiation Factor 2B‐Positive Systemic Sclerosis‐Associated Interstitial Lung Disease With Progressive Fibrosis: A Case Report

open access: yesRespirology Case Reports, Volume 14, Issue 1, January 2026.
We report the case of a patient with anti‐eIF2B‐positive SSc‐ILD managed with stepwise mycophenolate titration and subsequent nintedanib addition, accompanied by serial biomarkers and clinical follow‐up to help delineate the therapeutic course within this rare serological phenotype.
Hiro Ikeda   +3 more
wiley   +1 more source

Home - About - Disclaimer - Privacy